title: Erlotinib treatment of meningeal carcinomatosis in lung cancer: more is better.
authors: Department of Medical Oncology, Université Paris Descartes. Electronic address: anatole.cessot@cch.aphp.fr.
authors: A
authors: A
authors: Cessot
authors: Department of Pharmacology, Cochin Teaching Hospital, Paris, France.
authors: B
authors: B
authors: Blanchet
authors: Department of Medical Oncology, Université Paris Descartes.
authors: F
authors: F
authors: Goldwasser
mesh_terms: D066246:ErbB Receptors / Q000235:genetics; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D055756:Meningeal Carcinomatosis / Q000188:drug therapy / Q000235:genetics / Q000473:pathology* / Q000556:secondary; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011799:Quinazolines / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors